Test device and method for colored particle immunoassay

• US 5,714,389 A
• Filed: 12/23/1992
• Issued: 02/03/1998
• Est. Priority Date: 06/27/1988
• Status: Expired due to Term

• Current Assignee: Church & Dwight Company Incorporated
• Original Assignee: Carter-Wallace Incorporated
• Inventors: Charlton, David E., Miller, Neal W.
• Primary Examiner(s): CHIN, CHRISTOPHER L
• Application Number:
  US07/995,331
• Time in Patent Office: 1,868 Days
• Field of Search: 436/514, 436/518, 436/523, 436/524, 436/525, 436/533, 436/544, 436/169, 436/178, 436/810, 436/814, 436/817, 436/818, 436/501, 436/515, 435/176, 435/7.92, 435/970, 422/56, 422/55, 422/57, 427/2
• US Class Current: 436/514
• CPC Class Codes: B01L 2300/0681 Filter
• CPC Class Codes: B01L 2300/0825 Test strips
• CPC Class Codes: B01L 2400/0406 capillary forces
• CPC Class Codes: B01L 3/5023 with a sample being transported to, and subsequently stored in an absorbent for analysis
• CPC Class Codes: G01N 33/54313 the carrier being characterised by its particulate form
• CPC Class Codes: G01N 33/54366 Apparatus specially adapted for solid-phase testing
• CPC Class Codes: G01N 33/743 Steroid hormones
• CPC Class Codes: G01N 33/76 Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
• CPC Class Codes: Y10S 435/805 Test papers
• CPC Class Codes: Y10S 435/81 Packaged device or kit
• CPC Class Codes: Y10S 435/97 Test strip or test slide
• CPC Class Codes: Y10S 436/81 Tube, bottle, or dipstick
• CPC Class Codes: Y10S 436/814 Pregnancy
• CPC Class Codes: Y10S 436/817 Steroids or hormones
• CPC Class Codes: Y10S 436/818 Human chorionic gonadotropin
• CPC Class Codes: Y10T 436/255 including use of a solid sorbent, semipermeable membrane, or liquid extraction

Abstract

Disclosed is a test cell and a method for detection of a preselected ligand in a liquid sample such as a body fluid. The test cell includes an elongate outer casing which houses an interior permeable material capable of transporting an aqueous solution and defining a sample inlet, a test volume, and a reservoir volume. The reservoir volume is disposed in a section of the test cell spaced apart from the inlet and is filled with sorbent material. The reservoir acts to receive liquid transported along a flow path defined by the permeable material and extending from the inlet and through the test volume. In the test volume is a test site which includes a first protein having a binding site specific to a first epitope of the ligand immobilized in fluid communication with the flow path. The test site can be observed through a window of the casing.

Claims

1. A method of detecting a ligand in a liquid sample suspected of containing said ligand, the method comprising the steps of:

(a) providing a test strip, disposed within a housing, comprising sorbent material and defining a flow path, a sample inlet and, spaced apart from said inlet in said flow path,

a test site having immobilized thereon a first protein having a binding site specific for a first epitope on said ligand and a separate control site;

(b) providing a conjugate comprising colored particulate material coupled to a second protein having a binding site specific for a second epitope on said ligand;

(c) applying to said inlet said liquid sample;

(d) transporting to said test site and said control site by sorption, capillary action, wicking, or wetting along said flow path said liquid sample in admixture with said conjugate

thereby to produce,

at said control site, color indicative of a valid test result and indicative that conjugate has bound specifically or non-specifically at said control site, and

at said test site, of said ligand is present in said liquid sample, a specific binding reaction product comprising said ligand and an aggregate of said colored particulate material to produce a color visible to the unaided eye indicative of the presence of said ligand.

2. The method of claim 1 wherein said flow path further comprises a filtration means disposed between said inlet and said test site and said step (d) further comprises:

filtering said liquid sample through said filtration means prior to said liquid sample contacting said test site.

3. The method of claim 1 wherein said control site is downstream of said test site and comprises binding protein which specifically binds conjugate.

4. The method of claim 1 further comprising the step of mixing said conjugate with said liquid sample to form the admixture of step (d) prior to applying said liquid sample to said inlet.

5. The method of claim 1 wherein a solution consisting essentially of said conjugate is applied at a location in said flow path upstream of said test site and dried on said test strip prior to step (c), said method further comprising the step of transporting said liquid sample into contact with said dried conjugate prior to contact with said test site.

6. The method of claim 1 wherein said first and second proteins are antibodies and at least one of said antibodies is a monoclonal antibody.

7. The method of claim 1 wherein said first protein has binding site specific to an epitope of human chorionic gonadotropin (hCG) and said ligand is hCG.

8. A method of claim 1 wherein said first protein has a binding site specific to an epitope of human progesterone and said ligand is progesterone.

9. A method of detecting a ligand in a liquid sample suspected of containing said ligand, the method comprising the steps of:

(a) providing a test strip, disposed within a housing, comprising sorbent material and defining

a flow path,

a sample inlet, and, spaced apart from said inlet in said flow path,

a test site having immobilized thereon a first protein having a binding site specific for a first epitope on said ligand, and

a separate control site;

(b) providing a conjugate comprising a metal sol particle coupled to a second protein having a binding site specific for a second epitope on said ligand;

(c) applying to said inlet said liquid sample; and

(d) transporting to said test site and said control site by sorption, capillary action, wicking or wetting along said flow path said liquid sample in admixture with said conjugate,

thereby to produce,

at said control site, color indicative of a valid test result and indicative that conjugate has bound specifically or non-specifically at said control site, and

at said test site, if said ligand is present in said liquid sample, a specific binding reaction product comprising said ligand and an aggregate of said metal sol particle to produce a color visible to the unaided eye indicative of the presence of said ligand.

10. A method of detecting a ligand in a liquid sample suspected of containing said ligand, the method comprising the steps of:

(a) providing a test strip, disposed within a housing, comprising sorbent material and defining

a flow path,

a sample inlet, and, spaced apart from said inlet in said flow path,

a test site having immobilized thereon a first protein having a binding site specific for a first epitope on said ligand,

a separate control site, and disposed in said flow path upstream of said test site,

a dried reagent consisting essentional of a conjugate comprising colored particulate material coupled to a second protein having a binding site specific for a second epitope on said ligand;

(b) applying to said inlet said liquid sample; and

(c) transporting by sorption, capillary action, wicking or wetting along said flow path said liquid sample into contact with said dried conjugate to produce an admixture of said liquid sample and said conjugate, and thereafter transporting said admixture into contact with said test site and said control site thereby to produce,

at said control site, color indicative of a valid test result and indicative that conjugate has bound specifically or non-specifically at said control site, and

at said test site, if said ligand is present in said liquid sample, a specific binding reaction product comprising said ligand and an aggregate of said colored particulate material to produce a color visible to the unaided eye indicative of the presence of said ligand.